JPH11106311A - Hyaluronidase activity inhibitor and its use - Google Patents
Hyaluronidase activity inhibitor and its useInfo
- Publication number
- JPH11106311A JPH11106311A JP10209861A JP20986198A JPH11106311A JP H11106311 A JPH11106311 A JP H11106311A JP 10209861 A JP10209861 A JP 10209861A JP 20986198 A JP20986198 A JP 20986198A JP H11106311 A JPH11106311 A JP H11106311A
- Authority
- JP
- Japan
- Prior art keywords
- name
- indonesia
- scientific name
- scientific
- hyaluronidase activity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000000694 effects Effects 0.000 title claims abstract description 43
- 108010003272 Hyaluronate lyase Proteins 0.000 title claims abstract description 38
- 102000001974 Hyaluronidases Human genes 0.000 title claims abstract description 38
- 229960002773 hyaluronidase Drugs 0.000 title claims abstract description 38
- 239000003112 inhibitor Substances 0.000 title claims abstract description 20
- 239000000284 extract Substances 0.000 claims abstract description 58
- 241000196324 Embryophyta Species 0.000 claims abstract description 19
- 239000003814 drug Substances 0.000 claims abstract description 18
- 239000002904 solvent Substances 0.000 claims abstract description 15
- 229940079593 drug Drugs 0.000 claims abstract description 13
- 239000002537 cosmetic Substances 0.000 claims abstract description 10
- 239000004480 active ingredient Substances 0.000 claims abstract description 9
- 235000013305 food Nutrition 0.000 claims abstract description 8
- 244000061408 Eugenia caryophyllata Species 0.000 claims abstract description 7
- 235000016639 Syzygium aromaticum Nutrition 0.000 claims abstract description 7
- 241000723347 Cinnamomum Species 0.000 claims abstract description 6
- 241001112084 Elaeocarpus Species 0.000 claims abstract description 6
- 235000015070 Elaeocarpus Nutrition 0.000 claims abstract description 6
- 240000008395 Elaeocarpus angustifolius Species 0.000 claims abstract description 6
- 235000006843 Elaeocarpus angustifolius Nutrition 0.000 claims abstract description 6
- 241000920652 Quercus lusitanica Species 0.000 claims abstract description 6
- 241001163123 Syzygium micranthum Species 0.000 claims abstract description 6
- 241000283956 Manis Species 0.000 claims abstract description 5
- 235000013399 edible fruits Nutrition 0.000 claims description 17
- 244000081822 Uncaria gambir Species 0.000 claims description 10
- 235000012097 Eugenia cumini Nutrition 0.000 claims description 8
- 244000060474 Eugenia jambolana Species 0.000 claims description 8
- 244000042271 Eugenia polyantha Species 0.000 claims description 7
- 240000002839 Adenostemma lavenia Species 0.000 claims description 5
- 244000226021 Anacardium occidentale Species 0.000 claims description 5
- 235000001274 Anacardium occidentale Nutrition 0.000 claims description 5
- 240000001902 Basilicum polystachyon Species 0.000 claims description 5
- 244000037364 Cinnamomum aromaticum Species 0.000 claims description 5
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims description 5
- 235000021511 Cinnamomum cassia Nutrition 0.000 claims description 5
- 244000249716 Elaeocarpus stipularis Species 0.000 claims description 5
- 235000011276 Elaeocarpus stipularis Nutrition 0.000 claims description 5
- 244000227032 Guazuma ulmifolia Species 0.000 claims description 5
- 235000010238 Guazuma ulmifolia Nutrition 0.000 claims description 5
- 240000007972 Hyptis brevipes Species 0.000 claims description 5
- 244000118351 Pluchea indica Species 0.000 claims description 5
- 235000015471 Pluchea indica Nutrition 0.000 claims description 5
- 244000294611 Punica granatum Species 0.000 claims description 5
- 235000014360 Punica granatum Nutrition 0.000 claims description 5
- 235000012023 Terminalia bellirica Nutrition 0.000 claims description 5
- 241000530146 Clerodendrum buchananii Species 0.000 claims description 4
- 241000238631 Hexapoda Species 0.000 claims description 4
- 241001602876 Nata Species 0.000 claims description 2
- 235000020986 nuts and seeds Nutrition 0.000 claims description 2
- 244000191422 Terminalia bellirica Species 0.000 claims 2
- 230000002401 inhibitory effect Effects 0.000 abstract description 15
- 238000013329 compounding Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 description 42
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 35
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 34
- 238000004519 manufacturing process Methods 0.000 description 31
- 239000008213 purified water Substances 0.000 description 17
- 238000002360 preparation method Methods 0.000 description 14
- 239000000047 product Substances 0.000 description 12
- 238000009472 formulation Methods 0.000 description 11
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 7
- 238000010438 heat treatment Methods 0.000 description 7
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000006071 cream Substances 0.000 description 6
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 5
- 241000699666 Mus <mouse, genus> Species 0.000 description 5
- 229960000265 cromoglicic acid Drugs 0.000 description 5
- VLARUOGDXDTHEH-UHFFFAOYSA-L disodium cromoglycate Chemical compound [Na+].[Na+].O1C(C([O-])=O)=CC(=O)C2=C1C=CC=C2OCC(O)COC1=CC=CC2=C1C(=O)C=C(C([O-])=O)O2 VLARUOGDXDTHEH-UHFFFAOYSA-L 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 229920002674 hyaluronan Polymers 0.000 description 5
- 229960003160 hyaluronic acid Drugs 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 239000002202 Polyethylene glycol Substances 0.000 description 4
- 235000014510 cooky Nutrition 0.000 description 4
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 4
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 4
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 4
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 239000006210 lotion Substances 0.000 description 4
- 239000000419 plant extract Substances 0.000 description 4
- 239000002798 polar solvent Substances 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- 229940058015 1,3-butylene glycol Drugs 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 235000021355 Stearic acid Nutrition 0.000 description 3
- 244000131310 Terminalia belirica Species 0.000 description 3
- 235000019437 butane-1,3-diol Nutrition 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 229960000735 docosanol Drugs 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 229940075507 glyceryl monostearate Drugs 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 3
- 235000002639 sodium chloride Nutrition 0.000 description 3
- 239000008117 stearic acid Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 150000005846 sugar alcohols Polymers 0.000 description 3
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 3
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 2
- 229920002261 Corn starch Polymers 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 102220483782 Myb/SANT-like DNA-binding domain-containing protein 1_A21D_mutation Human genes 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- IPQKDIRUZHOIOM-UHFFFAOYSA-N Oroxin A Natural products OC1C(O)C(O)C(CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IPQKDIRUZHOIOM-UHFFFAOYSA-N 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- -1 Polyoxyethylene cetyl ether Polymers 0.000 description 2
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 229960001138 acetylsalicylic acid Drugs 0.000 description 2
- AQHDANHUMGXSJZ-UHFFFAOYSA-N baicalin Natural products OC1C(O)C(C(O)CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 AQHDANHUMGXSJZ-UHFFFAOYSA-N 0.000 description 2
- IKIIZLYTISPENI-ZFORQUDYSA-N baicalin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IKIIZLYTISPENI-ZFORQUDYSA-N 0.000 description 2
- 229960003321 baicalin Drugs 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 2
- 239000004327 boric acid Substances 0.000 description 2
- 235000010338 boric acid Nutrition 0.000 description 2
- 239000002738 chelating agent Substances 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 239000008120 corn starch Substances 0.000 description 2
- DIOQZVSQGTUSAI-UHFFFAOYSA-N decane Chemical compound CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 2
- 239000001685 glycyrrhizic acid Substances 0.000 description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 description 2
- 235000019410 glycyrrhizin Nutrition 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- 239000008311 hydrophilic ointment Substances 0.000 description 2
- 229960000905 indomethacin Drugs 0.000 description 2
- ZGEGCLOFRBLKSE-UHFFFAOYSA-N methylene hexane Natural products CCCCCC=C ZGEGCLOFRBLKSE-UHFFFAOYSA-N 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- BKIMMITUMNQMOS-UHFFFAOYSA-N nonane Chemical compound CCCCCCCCC BKIMMITUMNQMOS-UHFFFAOYSA-N 0.000 description 2
- 239000003002 pH adjusting agent Substances 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 2
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 235000013772 propylene glycol Nutrition 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 235000011121 sodium hydroxide Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- SWFHGTMLYIBPPA-UHFFFAOYSA-N (4-methoxyphenyl)-phenylmethanone Chemical compound C1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 SWFHGTMLYIBPPA-UHFFFAOYSA-N 0.000 description 1
- WSWCOQWTEOXDQX-MQQKCMAXSA-M (E,E)-sorbate Chemical compound C\C=C\C=C\C([O-])=O WSWCOQWTEOXDQX-MQQKCMAXSA-M 0.000 description 1
- LIKMAJRDDDTEIG-UHFFFAOYSA-N 1-hexene Chemical compound CCCCC=C LIKMAJRDDDTEIG-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- NDNMXRYLRJEZAR-UHFFFAOYSA-N 2-[1-(4-methoxyphenyl)propylidene]octanoic acid Chemical compound CCCCCCC(C(O)=O)=C(CC)C1=CC=C(OC)C=C1 NDNMXRYLRJEZAR-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- BGNGWHSBYQYVRX-UHFFFAOYSA-N 4-(dimethylamino)benzaldehyde Chemical compound CN(C)C1=CC=C(C=O)C=C1 BGNGWHSBYQYVRX-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 229920000045 Dermatan sulfate Polymers 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 102000016359 Fibronectins Human genes 0.000 description 1
- 108010067306 Fibronectins Proteins 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 244000062730 Melissa officinalis Species 0.000 description 1
- 235000010654 Melissa officinalis Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 240000007994 Rhodomyrtus tomentosa Species 0.000 description 1
- 208000006981 Skin Abnormalities Diseases 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 239000008351 acetate buffer Substances 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- WJGAPUXHSQQWQF-UHFFFAOYSA-N acetic acid;hydrochloride Chemical compound Cl.CC(O)=O WJGAPUXHSQQWQF-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 229940050390 benzoate Drugs 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 229960005188 collagen Drugs 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 229940071120 dehydroacetate Drugs 0.000 description 1
- AVJBPWGFOQAPRH-FWMKGIEWSA-L dermatan sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS([O-])(=O)=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](C([O-])=O)O1 AVJBPWGFOQAPRH-FWMKGIEWSA-L 0.000 description 1
- 229940051593 dermatan sulfate Drugs 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-N diphosphoric acid Chemical compound OP(O)(=O)OP(O)(O)=O XPPKVPWEQAFLFU-UHFFFAOYSA-N 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 229960001484 edetic acid Drugs 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 231100001048 fetal toxicity Toxicity 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 230000005722 itchiness Effects 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 239000000473 propyl gallate Substances 0.000 description 1
- 235000010388 propyl gallate Nutrition 0.000 description 1
- 229940075579 propyl gallate Drugs 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 229940005657 pyrophosphoric acid Drugs 0.000 description 1
- 239000001651 pyrus cydonia seed extract Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- 229960001860 salicylate Drugs 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- 229940075554 sorbate Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 229930195735 unsaturated hydrocarbon Natural products 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Landscapes
- Anti-Oxidant Or Stabilizer Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Bakery Products And Manufacturing Methods Therefor (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、特定の植物の溶媒
抽出液を含有するヒアルロニダーゼ活性阻害剤に関する
ものであって、より詳しくは、特定の植物の特定部位ま
たは全草の溶媒抽出液を有効成分とする、化粧料、医薬
品、医薬部外品あるいは食品等に配合して用いられるヒ
アルロニダーゼ活性阻害剤に関するものである。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a hyaluronidase activity inhibitor containing a solvent extract of a specific plant and, more particularly, to a solvent extract of a specific site of a specific plant or a whole plant. The present invention relates to a hyaluronidase activity inhibitor used as a component in cosmetics, pharmaceuticals, quasi-drugs, foods and the like.
【0002】[0002]
【従来の技術および問題点】ヒアルロニダーゼは、通常
生体中の組織に不活性な状態で存在しており、生体内外
から何らかの刺激においてヒアルロニダーゼが活性化さ
れ、基質である高分子ヒアルロン酸が低分子化され、こ
れが起炎物質となり、炎症が進行すると言われている。
また、ヒアルロン酸の低分子化により、皮膚に関しては
皮膚保湿性、張り等の低下を招くことが推察されてい
る。そこで in vitro においてグリチルリチン酸、クロ
モグリク酸ナトリウム、バイカリン、インドメタシン、
アスピリン等に高いヒアルロニダーゼ活性阻害作用が確
認され、これらは現在抗炎症剤として使用されている。2. Description of the Related Art Hyaluronidase is usually present in an inactive state in tissues of a living body. Hyaluronidase is activated by some kind of stimulus from inside or outside the living body, and the high molecular weight hyaluronic acid as a substrate is reduced in molecular weight. It is said that this becomes an inflammatory substance and inflammation progresses.
In addition, it has been speculated that the reduction in molecular weight of hyaluronic acid causes a decrease in skin moisturizing property, tension and the like with respect to skin. Therefore, in vitro, glycyrrhizic acid, sodium cromoglycate, baicalin, indomethacin,
Aspirin and the like have a high hyaluronidase activity inhibitory effect, and these are currently used as anti-inflammatory agents.
【0003】しかしながらグリチルリチン酸およびバイ
カリンは、極微量で甘味を有し、もしくは鮮やかな朱色
の色調を有しており、天然物で古来使用されており安全
性は比較的高いものと言われているが、用途および使用
濃度に制限がある。また、クロモグリク酸ナトリウム
は、妊婦投与時の胎児毒性の報告があり、医薬品として
厳重な使用上の注意を要する。さらに、インドメタシン
およびアスピリンは、局所的な使用で発疹・痒み等の副
作用が認められており、それぞれに問題点を抱えてい
る。[0003] However, glycyrrhizic acid and baicalin have a very small amount of sweetness or a vivid vermilion color, are used as natural products since ancient times, and are said to have relatively high safety. However, there are restrictions on applications and concentrations used. In addition, sodium cromoglycate has been reported to have fetal toxicity upon administration to pregnant women and requires strict caution in its use as a pharmaceutical. Further, indomethacin and aspirin have been observed to have side effects such as rash and itchiness when used topically, and each has problems.
【0004】このようにこれらは安全性、品質、有用性
等で問題を抱えており、使用が制限された範囲での利用
に留まっている。そこで人体にとって皮膚に塗布した
り、あるいは食しても安全で、ヒアルロン酸の低分子化
に対して顕著に抑制作用を有し、容易に製造可能なヒア
ルロニダーゼ活性阻害剤の開発が望まれていた。[0004] As described above, they have problems in safety, quality, usefulness and the like, and are limited to use in a limited range. Therefore, it has been desired to develop a hyaluronidase activity inhibitor which is safe for the human body to be applied to the skin or eats, has a remarkable inhibitory effect on the reduction of molecular weight of hyaluronic acid, and can be easily produced.
【0005】[0005]
【発明が解決しようとする課題】本発明の目的は、医薬
品に見られる様な副作用のない、ヒアルロニダーゼ活性
阻害作用が強いヒアルロニダーゼ活性阻害剤を提供する
ことにある。SUMMARY OF THE INVENTION It is an object of the present invention to provide a hyaluronidase activity inhibitor which has no side effects as seen in pharmaceutical products and has a strong inhibitory effect on hyaluronidase activity.
【0006】[0006]
【課題を解決するための手段】本発明は、上記目的を達
成するために提案されたものであって、本発明者らの長
年にわたる研究の結果として見いだされた、特定のイン
ドネシア産薬草・薬木の特定部位あるいは全草から抽出
された抽出液がヒアルロニダーゼ活性阻害作用を有する
との新知見に基づいて完成したものである。DISCLOSURE OF THE INVENTION The present invention has been proposed to achieve the above object, and has been found as a result of a long-term study by the inventors of the present invention. The present invention has been completed based on a new finding that an extract extracted from a specific part of a tree or whole plant has a hyaluronidase activity inhibitory action.
【0007】すなわち、本発明によれば、 学名:Eugenia polyantha Wight (インドネシア名:B
abakan salam)、 学名:Cinnamomum burmani Nees ex Bl.(インドネシア
名:Kayu manis)、 学名:Eugenia aromatica O.K.(インドネシア名:Ce
ngkeh)、 学名:Quercus lusitanica Lamk (インドネシア名:M
ajakani)、 学名:Elaeocarpus ganitrus Roxb.(インドネシア名:
Jenitri)、 学名:Elaeocarpus oxypyrena K.& V.(インドネシア
名:Jenitri)、 学名:Elaeocarpus stipularis Bl.(インドネシア名:
Jenitri)、 学名:Punica granatum L.(インドネシア名:Deli
ma putih)、 学名:Terminalia belerica Roxb. (インドネシア名:
Jaha)、 学名:Cinnamomum cassia Nees ex B1. (インドネシア
名:Kembang lawang)、 学名:Eugenia cumini Merr.(インドネシア名:Bab
akan duwet)、 学名:Anacardium occidentale L. (インドネシア名:
Daun jambumete)、 学名:Guazuma ulmifolia Lmk var. tomentosa K.Schu
m. (インドネシア名:Daun jati bela
nda)、 学名:Moschosma polystachyon (L.) Bth.(インドネシ
ア名:Daun sangket)、 学名:Uncaria gambir (Hunter) Roxb. (インドネシア
名:Gambir)、 学名:Adenostemma lavenia(L.)O.K. (インドネシア
名:Legetan warak)、 学名:Pluchea indica(L.)Less(インドネシア名:Lu
ntas)、 学名:Hyptis brevipes Poit. (インドネシア名:Go
ndong puser)、 からなる群より選ばれる少なくとも一種以上の植物の溶
媒抽出液を有効成分として含有することを特徴とするヒ
アルロニダーゼ活性阻害剤が提供される。That is, according to the present invention, scientific name: Eugenia polyantha Wight (Indonesia name: B
abacan salam), Scientific name: Cinnamomum burmani Nees ex Bl. (Indonesia name: Kayu manis), Scientific name: Eugenia aromatica OK (Indonesia name: Ce)
ngkeh), Scientific name: Quercus lusitanica Lamk (Indonesia name: M
ajakani), Scientific name: Elaeocarpus ganitrus Roxb. (Indonesia name:
Jenitri), Scientific name: Elaeocarpus oxypyrena K. & V. (Indonesia name: Jenitri), Scientific name: Elaeocarpus stipularis Bl. (Indonesia name:
Jenitri), Scientific name: Punica granatum L. (Indonesia name: Deli)
ma putih), Scientific name: Terminalia belerica Roxb. (Indonesia name:
(Jaha), Scientific name: Cinnamomum cassia Nees ex B1. (Indonesia name: Kembang lawang), Scientific name: Eugenia cumini Merr. (Indonesia name: Bab)
akan duwet), Scientific name: Anacardium occidentale L. (Indonesia name:
Daun jambume), Scientific name: Guazuma ulmifolia Lmk var. Tomentosa K. Schu
m. (Indonesia name: Daun jati bela
nda), Scientific name: Moschosma polystachyon (L.) Bth. (Indonesia name: Daun sangket), Scientific name: Uncaria gambir (Hunter) Roxb. (Indonesia name: Gambir), Scientific name: Adenostemma lavenia (L.) OK (Indonesia name: Legetan warak), Scientific name: Pluchea indica (L.) Less (Indonesia name: Lu)
ntas), Scientific name: Hyptis brevipes Poit. (Indonesia name: Go)
a hyaluronidase activity inhibitor comprising, as an active ingredient, at least one solvent extract of a plant selected from the group consisting of:
【0008】また、本発明によれば、 学名:Eugenia polyantha Wight (インドネシア名:B
abakan salam)の樹皮、根、葉および実、 学名:Cinnamomum burmani Nees ex Bl.(インドネシア
名:Kayu manis)の樹皮、 学名:Eugenia aromatica O.K.(インドネシア名:Ce
ngkeh)花蕾、花および葉、 学名:Quercus lusitanica Lamk (インドネシア名:M
ajakani)の虫えい、実および葉、 学名:Elaeocarpus ganitrus Roxb.(インドネシア名:
Jenitri)の実、 学名:Elaeocarpus oxypyrena K.& V.(インドネシア
名:Jenitri)の実、 学名:Elaeocarpus stipularis Bl.(インドネシア名:
Jenitri)の実、 学名:Punica granatum L.(インドネシア名:Deli
ma putih)の果皮、根被、花および実、 学名:Terminalia belerica Roxb. (インドネシア名:
Jaha)の実、 学名:Cinnamomum cassia Nees ex B1. (インドネシア
名:Kembang lawang)の実、根および樹
皮、 学名:Eugenia cumini Merr.(インドネシア名:Bab
akan duwet)の樹皮、葉、実および種子、 学名:Anacardium occidentale L. (インドネシア名:
Daun jambumete)の葉、根、樹皮、実、
種子、 学名:Guazuma ulmifolia Lmk var. tomentosa K.Schu
m. (インドネシア名:Daun jati bela
nda)の葉、実、樹皮および種子、 学名:Moschosma polystachyon (L.) Bth.(インドネシ
ア名:Daun sangket)の全草および葉、 学名:Uncaria gambir (Hunter) Roxb. (インドネシア
名:Gambir)の茎、葉および樹液、 学名:Adenostemma lavenia(L.)O.K. (インドネシア
名:Legetan warak)の全草、根および
葉、 学名:Pluchea indica(L.)Less(インドネシア名:Lu
ntas)の茎、葉、根、種子および樹液、および、 学名:Hyptis brevipes Poit. (インドネシア名:Go
ndong puser)の葉および茎、 からなる群より選ばれる少なくとも一種以上の植物の溶
媒抽出液を有効成分として含有することを特徴とするヒ
アルロニダーゼ活性阻害剤が提供される。上記ヒアルロ
ニダーゼ活性阻害剤は、化粧料、医薬品、医薬部外品お
よび食品に配合して有効に用いられる。According to the present invention, a scientific name: Eugenia polyantha Wight (Indonesia name: B
bark, root, leaf and fruit of Abakan salam, Scientific name: Cinnamomum burmani Nees ex Bl. (Indonesia name: Kayu manis) Bark, Scientific name: Eugenia aromatica OK (Indonesia name: Ce)
ngkeh) flower buds, flowers and leaves, scientific name: Quercus lusitanica Lamk (Indonesia name: M
ajakani) insects, fruits and leaves, scientific name: Elaeocarpus ganitrus Roxb. (Indonesia name:
Jenitri) Fruit, Scientific name: Elaeocarpus oxypyrena K. & V. (Indonesia name: Jenitri) Fruit, Scientific name: Elaeocarpus stipularis Bl. (Indonesia name:
Jenitri fruit, Scientific name: Punica granatum L. (Indonesia name: Deli)
ma putih) peel, root cover, flower and fruit, Scientific name: Terminalia belerica Roxb. (Indonesia name:
(Jaha) Fruit, Scientific name: Cinnamomum cassia Nees ex B1. (Indonesia name: Kembang lawang) Fruit, root and bark, Scientific name: Eugenia cumini Merr. (Indonesia name: Bab)
akan duwet bark, leaves, nuts and seeds, scientific name: Anacardium occidentale L. (Indonesia name:
Daun jambumete) leaves, roots, bark, nuts,
Seed, scientific name: Guazuma ulmifolia Lmk var. Tomentosa K. Schu
m. (Indonesia name: Daun jati bela
nda) leaves, nuts, bark and seeds, scientific name: whole plant and leaves of Moschosma polystachyon (L.) Bth. (Indonesia name: Daun sangket), scientific name: Uncaria gambir (Hunter) Roxb. (Indonesia name: Gambir) Stem, leaf and sap, Scientific name: Adenostemma lavenia (L.) OK (Indonesia name: Legetan warak) Whole plant, root and leaf, Scientific name: Pluchea indica (L.) Less (Indonesia name: Lu)
nata) stem, leaves, roots, seeds and sap, and scientific name: Hyptis brevipes Poit. (Indonesia name: Go
and a solvent extract of at least one plant selected from the group consisting of leaves and stalks of a non-drug user as an active ingredient. The above-mentioned hyaluronidase activity inhibitor is effectively used by being blended into cosmetics, pharmaceuticals, quasi-drugs and foods.
【0009】[0009]
【発明の実施の形態】本発明で使用する上記特定の植物
は、インドネシアで古来生薬として、一般に複数の混合
物の熱水抽出液を飲用し、腹痛、頭痛等の症状の治療に
利用されている。本発明においては、上記特定の植物の
根、茎、木部、葉、果実(種子も含む)、花蕾、樹皮、
虫えい等が利用部位として用いられ、この抽出液にヒア
ルロニダーゼ活性阻害作用があることを見いだしたこと
に重要な意義がある。BEST MODE FOR CARRYING OUT THE INVENTION The above-mentioned specific plant used in the present invention is commonly used as a crude drug in Indonesia, for drinking a hot water extract of a plurality of mixtures and treating abdominal pain, headache and other symptoms in Indonesia. . In the present invention, the roots, stems, xylem, leaves, fruits (including seeds), flower buds, bark,
Insects and the like are used as utilization sites, and it is important to find that this extract has a hyaluronidase activity inhibitory action.
【0010】抽出は、溶媒によって行うが、抽出溶媒と
しては、低級アルコール、多価アルコール、低極性溶媒
および極性溶媒を使用する。低級アルコールとしては、
メタノール、エタノール、プロパノール及びイソプロピ
ルアルコール等が使用される。多価アルコールとして
は、グリセリン、ポリエチレングリコール、低極性溶媒
としては、ペンタン、ヘキサン、ヘプタン、オクタン、
ノナン、デカン等の飽和炭化水素;ヘキセン、ヘプテン
等の不飽和炭化水素;極性溶媒としては、水、アセト
ン、酢酸エチル、酢酸メチル等が使用され、これらの単
用または2種以上を併用して抽出溶媒として用いられ
る。The extraction is carried out with a solvent. As the extraction solvent, a lower alcohol, a polyhydric alcohol, a low polar solvent and a polar solvent are used. As a lower alcohol,
Methanol, ethanol, propanol and isopropyl alcohol are used. Polyhydric alcohols include glycerin and polyethylene glycol, and low-polar solvents include pentane, hexane, heptane, octane,
Saturated hydrocarbons such as nonane and decane; unsaturated hydrocarbons such as hexene and heptene; as the polar solvent, water, acetone, ethyl acetate, methyl acetate and the like are used, and these may be used alone or in combination of two or more. Used as an extraction solvent.
【0011】抽出は、Eugenia polyantha Wight 等に溶
媒を加えて、必要あれば撹拌しながら1ないし60℃、
好ましくは室温以下で抽出を行う。但し、水の場合沸騰
した熱水で抽出してもよい。混合溶媒の使用量に格別の
限定はないが、一応の目安として乾燥植物(破砕物)1
部に対して溶媒を1ないし20部、好ましくは5ないし
10部程度とするのがよい。このようにして得られた抽
出液には、ヒアルロニダーゼ活性阻害作用成分が、高濃
度に含まれる。For the extraction, a solvent is added to Eugenia polyantha Wight or the like, and if necessary, stirring is performed at 1 to 60 ° C.
The extraction is preferably performed at room temperature or lower. However, in the case of water, it may be extracted with boiling hot water. There is no particular limitation on the amount of the mixed solvent used, but as a rough guide, dry plant (crushed material) 1
The solvent is used in an amount of 1 to 20 parts, preferably about 5 to 10 parts per part. The extract thus obtained contains a high concentration of a hyaluronidase activity inhibitory component.
【0012】本発明に係わるヒアルロニダーゼ活性阻害
剤は、上記の方法で抽出した抽出液をそのまま有用成分
として使用するほか、抽出液の精製物も有用成分として
使用することが出来る。該処理物としては、有用成分の
濃縮物、ペースト状物、乾燥物、及び/又は、希釈物が
広く使用される。As the hyaluronidase activity inhibitor according to the present invention, the extract extracted by the above method can be used as a useful component as it is, or a purified product of the extract can be used as a useful component. As the treated product, a concentrate, a paste, a dried product, and / or a diluted product of a useful component are widely used.
【0013】例えば、抽出液をそのまま真空(凍結)乾
燥したり、減圧濃縮した後、真空(凍結)乾燥したり、
あるいは減圧濃縮した後、各種溶媒で溶媒分画を行い、
ヒアルロニダーゼ活性阻害作用成分を精製し、真空(凍
結)乾燥したり、またあるいは、抽出液をカラムに負荷
した後、真空(凍結)乾燥するカラムクロマトグラフィ
ーを利用した濃縮精製方法によって処理物を製造しても
よい。尚、処理物としては、最終の乾燥工程まで行うこ
となく、それに至るまでの途中の上記した各工程で操作
を停止し、目的に応じた形状、濃縮物のものを選択使用
することも可能である。For example, the extract is vacuum (freeze) dried as it is, or concentrated under reduced pressure and then vacuum (freeze) dried,
Alternatively, after concentration under reduced pressure, perform solvent fractionation with various solvents,
The hyaluronidase activity inhibitory component is purified and dried (vacuum) dried, or alternatively, the extract is loaded on a column, and then the processed product is produced by a concentration purification method using column chromatography of vacuum (freeze) drying. You may. Incidentally, as the processed material, without performing the final drying step, the operation is stopped in each of the above-described steps on the way to the final drying step, and it is also possible to select and use a shape and a concentrate according to the purpose. is there.
【0014】本発明に係わるヒアルロニダーゼ活性阻害
剤は、化粧料、食品、医薬部外品、医薬品等に配合して
用いることができる。化粧料および医薬部外品・医薬品
の皮膚外用剤においては、各種任意成分(油剤、保湿
剤、増粘剤、防腐剤、乳化剤、キレート剤、顔料、pH
調整剤、薬効成分、紫外線吸収剤、香料)を適宜配合
し、クリーム、ミルクローション、ローション、ファン
デーション、パック、エッセンス、軟膏、ゲル剤、パウ
ダー、リップクリーム、口紅、サンケア、バスソルト等
のその目的に応じて任意の形態で製造することができ
る。The hyaluronidase activity inhibitor according to the present invention can be used by blending it in cosmetics, foods, quasi-drugs, pharmaceuticals and the like. In cosmetics and quasi-drugs / pharmaceutical skin preparations, various optional components (oils, humectants, thickeners, preservatives, emulsifiers, chelating agents, pigments, pH
Modifiers, medicinal ingredients, UV absorbers, fragrances) are appropriately blended and used for creams, milk lotions, lotions, foundations, packs, essences, ointments, gels, powders, lip balms, lipsticks, sun care, bath salts, etc It can be manufactured in any form according to.
【0015】保湿剤としては、例えばグリセリン、プロ
ピレングリコール、1,3−ブチレングリコール、ソル
ビトール、マンニトール、ポリエチレングリコール、ジ
プロピレングリコール等の多価アルコール、アミノ酸、
乳酸ナトリウム、ピロリドンカルボン酸ナトリウム等の
NMF成分、ヒアルロン酸、コラーゲン、エラスチン、
コンドロイチン硫酸、デルマタン硫酸、フィブロネクチ
ン、ヘパリン類似物質、キトサン等の水溶性高分子物質
等を例示することができる。Examples of the humectant include polyhydric alcohols such as glycerin, propylene glycol, 1,3-butylene glycol, sorbitol, mannitol, polyethylene glycol and dipropylene glycol; amino acids;
NMF components such as sodium lactate and sodium pyrrolidonecarboxylate, hyaluronic acid, collagen, elastin,
Water-soluble polymer substances such as chondroitin sulfate, dermatan sulfate, fibronectin, heparin-like substances, and chitosan can be exemplified.
【0016】増粘剤としては、例えばアルギン酸ナトリ
ウム、キサンタンガム、マルメロ種子抽出物、トラガン
トゴム、デンプン等の天然高分子物質、メチルセルロー
ス、ヒドロキシエチルセルロース、カルボキシメチルセ
ルロース、可溶性デンプン、カチオン化セルロース等の
半合成高分子化合物、カルボキシビニルポリマー、ポリ
ビニルポリマー等の合成高分子物質等を例示することが
できる。Examples of the thickener include natural polymer substances such as sodium alginate, xanthan gum, quince seed extract, tragacanth gum, starch, and semi-synthetic polymers such as methyl cellulose, hydroxyethyl cellulose, carboxymethyl cellulose, soluble starch, and cationized cellulose. Examples thereof include compounds, synthetic high molecular substances such as carboxyvinyl polymers and polyvinyl polymers.
【0017】防腐剤としては、例えば安息香酸塩、サリ
チル酸塩、ソルビン酸塩、デヒドロ酢酸塩、パラオキシ
安息香酸エステル、2,4,4’−トリクロロ−2’−
ヒドロキシジフェニルエーテル、3,4,4’−トリク
ロロカルバニド、塩化ベンザルコニウム、ヒノキチオー
ル、レゾルシン、エタノール等を例示することができ
る。Examples of preservatives include benzoate, salicylate, sorbate, dehydroacetate, paraoxybenzoate, and 2,4,4'-trichloro-2'-.
Examples thereof include hydroxydiphenyl ether, 3,4,4′-trichlorocarbanide, benzalkonium chloride, hinokitiol, resorcinol, ethanol and the like.
【0018】酸化防止剤としては、例えばジブチルヒド
ロキシトルエン、ブチルヒドロキシアニソール、没食子
酸プロピル、アスコルビン酸等を例示することができ
る。紫外線吸収剤・遮蔽剤としては、例えば4−メトキ
シベンゾフェノン、オクチルジメチルパラアミノベンゾ
エート、エチルヘキシルパラメトキシシンナメート、酸
化チタン、カオリン、酸化亜鉛、タルク等を例示するこ
とができる。Examples of the antioxidant include dibutylhydroxytoluene, butylhydroxyanisole, propyl gallate, ascorbic acid and the like. Examples of the ultraviolet absorber / shielding agent include 4-methoxybenzophenone, octyldimethylparaaminobenzoate, ethylhexylparamethoxycinnamate, titanium oxide, kaolin, zinc oxide, talc and the like.
【0019】さらに、キレート剤としては、例えばエチ
レンジアミン四酢酸、ピロリン酸、ヘキサメタリン酸、
クエン酸、グルコン酸、酒石酸及びこれらの塩類を例示
することができ、pH調整剤としては、水酸化ナトリウ
ム、ホウ酸、ホウ砂、リン酸水素カリウム等をそれぞれ
例示することができる。Further, as a chelating agent, for example, ethylenediaminetetraacetic acid, pyrophosphoric acid, hexametaphosphoric acid,
Examples thereof include citric acid, gluconic acid, tartaric acid, and salts thereof, and examples of the pH adjuster include sodium hydroxide, boric acid, borax, potassium hydrogen phosphate, and the like.
【0020】[0020]
【製造例】本発明を実施例により具体的に説明するに先
立ち、本発明で使用したヒアルロニダーゼ活性阻害剤と
して有用なEuginia polyantha Wight 等の抽出液の製造
例を示す。[Preparation Examples] Before describing the present invention in more detail with reference to examples, examples of preparing an extract such as Euginia polyantha Wight useful as a hyaluronidase activity inhibitor used in the present invention will be described.
【0021】[製造例1]Eugenia polyantha Wight 樹
皮乾燥物の破砕物100gに対して、50 v/v%エタノ
ール1,000mlを加え、室温暗所にて7日間撹拌抽
出を行った。これを遠心分離・加圧ろ過し、抽出液を得
た。[Preparation Example 1] To 100 g of the crushed dried bark of Eugenia polyantha Wight was added 1,000 ml of 50 v / v% ethanol, and the mixture was stirred and extracted in a dark place at room temperature for 7 days. This was centrifuged and filtered under pressure to obtain an extract.
【0022】[製造例2]Cinnamomum burmani Nees ex
Bl.樹皮乾燥の破砕物100gに対して、100%エタ
ノール1,000mlを加え、室温暗所にて7日間撹拌
抽出を行った。これを遠心分離・加圧ろ過し、抽出液を
得た。[Production Example 2] Cinnamomum burmani Nees ex
1,000 ml of 100% ethanol was added to 100 g of Bl. Bark dried crushed product, and the mixture was stirred and extracted at room temperature in a dark place for 7 days. This was centrifuged and filtered under pressure to obtain an extract.
【0023】[製造例3]Eugenia aromatica O.K.花蕾
乾燥物の破砕物100gに対して、精製水1,000m
lを加え、湯浴上で1時間撹拌抽出を行った。これを遠
心分離・加圧ろ過し、抽出液を得た。[Production Example 3] Purified water of 1,000 m per 100 g of crushed dried Eugenia aromatica OK flower buds
1 was added, and the mixture was stirred and extracted on a hot water bath for 1 hour. This was centrifuged and filtered under pressure to obtain an extract.
【0024】[製造例4]Quercus lusitanica Lamk 虫
えい乾燥物の破砕物100gに対して、50 v/v%エタ
ノール1,000mlを加え、室温暗所にて7日間撹拌
抽出を行った。これを遠心分離・加圧ろ過し、抽出液を
得た。[Preparation Example 4] To 100 g of the crushed dried product of Quercus lusitanica Lamk insects was added 1,000 ml of 50 v / v% ethanol, and the mixture was stirred and extracted at room temperature in a dark place for 7 days. This was centrifuged and filtered under pressure to obtain an extract.
【0025】[製造例5]Elaeocarpus ganitrus Roxb.
実乾燥物の破砕物100gに対して、精製水1,000
mlを加え、湯浴上で1時間撹拌抽出を行った。これを
遠心分離・加圧ろ過し、抽出液を得た。[Production Example 5] Elaeocarpus ganitrus Roxb.
For 100 g of the crushed material of the actual dried product, 1,000 g of purified water
Then, the mixture was stirred and extracted on a hot water bath for 1 hour. This was centrifuged and filtered under pressure to obtain an extract.
【0026】[製造例6]Elaeocarpus oxypyrena K.&
V.実乾燥物の破砕物100gに対して、精製水1,00
0mlを加え、湯浴上で1時間撹拌抽出を行った。これ
を遠心分離・加圧ろ過し、抽出液を得た。[Production Example 6] Elaeocarpus oxypyrena K. &
V. 100 g of purified water was added to 100 g of crushed real dried product.
0 ml was added, and the mixture was stirred and extracted on a hot water bath for 1 hour. This was centrifuged and filtered under pressure to obtain an extract.
【0027】[製造例7]Elaeocarpus stipularis Bl.
実乾燥物の破砕物100gに対して、精製水1,000
mlを加え、湯浴上で1時間撹拌抽出を行った。これを
遠心分離・加圧ろ過し、抽出液を得た。[Production Example 7] Elaeocarpus stipularis Bl.
For 100 g of the crushed material of the actual dried product, 1,000 g of purified water
Then, the mixture was stirred and extracted on a hot water bath for 1 hour. This was centrifuged and filtered under pressure to obtain an extract.
【0028】[製造例8]Punica granatum L.果皮乾燥
物の破砕物100gに対して、精製水1,000mlを
加え、湯浴上で1時間撹拌抽出を行った。これを遠心分
離・加圧ろ過し、抽出液を得た。[Production Example 8] To 100 g of a crushed dried product of Punica granatum L. peel was added 1,000 ml of purified water, and the mixture was stirred and extracted on a hot water bath for 1 hour. This was centrifuged and filtered under pressure to obtain an extract.
【0029】[製造例9]Terminalia belerica Roxb.
実乾燥物の破砕物100gに対して、精製水1,000
mlを加え、湯浴上で1時間撹拌抽出を行った。これを
遠心分離・加圧ろ過し、抽出液を得た。[Production Example 9] Terminalia belerica Roxb.
For 100 g of the crushed material of the actual dried product, 1,000 g of purified water
Then, the mixture was stirred and extracted on a hot water bath for 1 hour. This was centrifuged and filtered under pressure to obtain an extract.
【0030】[製造例10]Cinnamomum cassia Nees e
x B1. 実乾燥物の破砕物100gに対して、精製水1,
000mlを加え、湯浴上で1時間撹拌抽出を行った。
これを遠心分離・加圧ろ過し、抽出液を得た。[Production Example 10] Cinnamomum cassia Nees e
x B1. Purified water 1
000 ml was added, and the mixture was stirred and extracted on a hot water bath for 1 hour.
This was centrifuged and filtered under pressure to obtain an extract.
【0031】[製造例11]Eugenia cumini Merr.樹皮
乾燥物の破砕物100gに対して、100v /v %エタ
ノール1,000mlを加え、室温暗所にて7日間撹拌
抽出を行った。これを遠心分離・加圧ろ過し、抽出液を
得た。[Production Example 11] To 100 g of crushed dried bark of Eugenia cumini Merr. Was added 1,000 ml of 100 v / v% ethanol, and the mixture was stirred and extracted at room temperature in a dark place for 7 days. This was centrifuged and filtered under pressure to obtain an extract.
【0032】[製造例12]Anacardium occidentale
L. 葉乾燥物の破砕物100gに対して、100 v/v%
エタノール1,000mlを加え、室温暗所にて7日間
撹拌抽出を行った。これを遠心分離・加圧ろ過し、抽出
液を得た。[Production Example 12] Anacardium occidentale
L. 100 v / v% for 100 g of crushed dried leaf
1,000 ml of ethanol was added, and the mixture was stirred and extracted in a dark place at room temperature for 7 days. This was centrifuged and filtered under pressure to obtain an extract.
【0033】[製造例13]Guazuma ulmifolia Lmk va
r. tomentosa K.Schum. 葉乾燥物の破砕物100gに対
して、精製水1,000mlを加え、湯浴上で1時間撹
拌抽出を行った。これを遠心分離・加圧ろ過し、抽出液
を得た。[Production Example 13] Guazuma ulmifolia Lmk va
To 100 g of the crushed r. tomentosa K. Schum. leaf dried product, 1,000 ml of purified water was added, and the mixture was stirred and extracted on a hot water bath for 1 hour. This was centrifuged and filtered under pressure to obtain an extract.
【0034】[製造例14]Moschosma polystachyon
(L.) Bth.全草乾燥物の破砕物100gに対して、精製
水1,000mlを加え、湯浴上で1時間撹拌抽出を行
った。これを遠心分離・加圧ろ過し、抽出液を得た。[Production Example 14] Moschosma polystachyon
(L.) 1000 ml of purified water was added to 100 g of the crushed dried whole plant Bth., And the mixture was stirred and extracted on a hot water bath for 1 hour. This was centrifuged and filtered under pressure to obtain an extract.
【0035】[製造例15]Uncaria gambir (Hunter)
Roxb. 茎・葉乾燥物の破砕物100gに対して、精製水
1,000mlを加え、湯浴上で1時間撹拌抽出を行っ
た。これを遠心分離・加圧ろ過し、抽出液を得た。[Production Example 15] Uncaria gambir (Hunter)
Roxb. 1,000 ml of purified water was added to 100 g of the crushed dried stem and leaf, and the mixture was stirred and extracted on a hot water bath for 1 hour. This was centrifuged and filtered under pressure to obtain an extract.
【0036】[製造例16]Eugenia cumini Merr.樹皮
乾燥物の破砕物100gに対して、アセトン1,000
mlを加え、室温暗所にて7日間撹拌抽出を行った。こ
れを遠心分離・加圧ろ過し、抽出液を得た。[Production Example 16] 100 g of crushed dried bark of Eugenia cumini Merr.
Then, the mixture was stirred and extracted in a dark place at room temperature for 7 days. This was centrifuged and filtered under pressure to obtain an extract.
【0037】[製造例17]Eugenia cumini Merr.樹皮
乾燥物の破砕物100gに対して、n−ヘキサン1,0
00mlを加え、室温暗所にて7日間撹拌抽出を行っ
た。これを遠心分離・加圧ろ過し、抽出液を得た。[Production Example 17] 100 g of a crushed dried bark of Eugenia cumini Merr.
After adding 00 ml, the mixture was extracted with stirring at room temperature in a dark place for 7 days. This was centrifuged and filtered under pressure to obtain an extract.
【0038】[製造例18]Eugenia cumini Merr.樹皮
乾燥物の破砕物100gに対して、グリセリン1,00
0mlを加え、室温暗所にて7日間撹拌抽出を行った。
これを遠心分離・加圧ろ過し、抽出液を得た。[Production Example 18] 100 g of crushed dried bark of Eugenia cumini Merr.
0 ml was added, and the mixture was stirred and extracted in a dark place at room temperature for 7 days.
This was centrifuged and filtered under pressure to obtain an extract.
【0039】[製造例19]Adenostemma lavenia(L.)
O.K. 全草乾燥物の破砕物100gに対して、精製水
1,000mlを加え、湯浴上で1時間撹拌抽出を行っ
た。これを遠心分離・加圧ろ過し、抽出物を得た。[Production Example 19] Adenostemma lavenia (L.)
OK 1,000 ml of purified water was added to 100 g of the crushed dried whole plant, and the mixture was stirred and extracted on a hot water bath for 1 hour. This was centrifuged and filtered under pressure to obtain an extract.
【0040】[製造例20]Pluchea indica(L.)Less
葉乾燥物の破砕物100gに対して、50v/v%エタ
ノール1,000mlを加え、室温暗所にて7日間撹拌
抽出を行った。これを遠心分離・加圧ろ過し、抽出物を
得た。[Production Example 20] Pluchea indica (L.) Less
1,000 ml of 50 v / v% ethanol was added to 100 g of the crushed dried leaf, and the mixture was extracted with stirring at room temperature in a dark place for 7 days. This was centrifuged and filtered under pressure to obtain an extract.
【0041】[製造例21]Hyptis brevipes Poit. 茎
葉乾燥物の破砕物100gに対して、精製水1,000
mlを加え、湯浴上で1時間撹拌抽出を行った。これを
遠心分離・加圧ろ過し、抽出物を得た。[Production Example 21] Hyptis brevipes Poit. Purified water 1,000 g per 100 g of crushed dried foliage
Then, the mixture was stirred and extracted on a hot water bath for 1 hour. This was centrifuged and filtered under pressure to obtain an extract.
【0042】[0042]
【実施例】上記製造例によって得られた抽出液を用いて
ヒアルロニダーゼ活性作用を試験し、化粧料、医薬品、
医薬部外品、食品としての適応性を検証した。EXAMPLE The hyaluronidase activity was tested using the extract obtained by the above production example, and it was applied to cosmetics, pharmaceuticals,
The applicability of quasi-drugs and foods was verified.
【0043】〔実施例1:ヒアルロニダーゼ活性阻害作
用試験〕各製造例による抽出液のヒアルロニダーゼ活性
阻害作用を下記の条件にて測定した。Example 1 Test of Hyaluronidase Activity Inhibiting Activity The hyaluronidase activity inhibiting effect of the extract of each Preparation Example was measured under the following conditions.
【0044】(1)測定方法 0.1M酢酸緩衝液(pH4.0)にて試料を10%に
希釈し、その希釈液0.2mlにヒアルロニダーゼ(T
ype IV−S)溶液0.1mlを加え、37℃で2
0分間インキュベートした。その後試薬0.2mlを加
え、さらに37℃で20分間インキュベートし、0.6
%ヒアルロン酸0.5mlを加え、37℃で40分間イ
ンキュベートした。0.4N水酸化ナトリウム溶液を
0.2mlを加え、反応停止する。その後ホウ酸試薬を
0.2ml加え、3分間ウォータバスで加熱する。p−
DAB試薬(p−ジメチルアミノベンズアルデヒド10
%塩酸−酢酸溶液)5mlを加え、37℃で20分間イ
ンキュベートし、585nmにて吸光値を測定し、下記
の阻害率の計算式より、阻害率(%)を求めた。 ヒアルロニダーゼ活性阻害率(%)=100 −{(試料無
添加時OD−試料添加時のOD)/試料無添加時OD}×100(1) Measurement method A sample was diluted to 10% with 0.1 M acetate buffer (pH 4.0), and 0.2 ml of the diluted solution was added to hyaluronidase (T
ype IV-S) solution and add 2 ml at 37 ° C.
Incubated for 0 minutes. Thereafter, 0.2 ml of a reagent was added, and the mixture was further incubated at 37 ° C. for 20 minutes.
0.5 ml of% hyaluronic acid was added and incubated at 37 ° C. for 40 minutes. The reaction is stopped by adding 0.2 ml of 0.4N sodium hydroxide solution. Thereafter, 0.2 ml of a boric acid reagent is added and the mixture is heated in a water bath for 3 minutes. p-
DAB reagent (p-dimethylaminobenzaldehyde 10
% Hydrochloric acid-acetic acid solution), and the mixture was incubated at 37 ° C. for 20 minutes, the absorbance was measured at 585 nm, and the inhibition rate (%) was obtained from the following inhibition rate calculation formula. Hyaluronidase activity inhibition rate (%) = 100-{(OD without sample-OD with sample added) / OD without sample} x 100
【0045】(2)測定結果 植物抽出液のヒアルロニダーゼ活性阻害作用の結果を表
1に示した。各々の抽出液は、クロモグリク酸ナトリウ
ム20%濃度に相当するヒアルロニダーゼ活性阻害作用
が認められた。(2) Measurement Results The results of the inhibitory effect of the plant extract on the hyaluronidase activity are shown in Table 1. In each extract, an inhibitory effect on hyaluronidase activity corresponding to a 20% concentration of sodium cromoglycate was observed.
【0046】[0046]
【表1】 [Table 1]
【0047】(3)考察 Eugenia polyantha Wight 等の抽出液は、乾燥植物破砕
物に対して10%濃度で抽出しており、ヒアルロニダー
ゼ活性阻害作用測定時の添加濃度は、乾燥物換算すると
1.0%以下となる。一方、クロモグリク酸ナトリウム
は、0.2%濃度で植物抽出液10%添加時と同程度の
阻害率となる。この結果から各々の抽出液には、クロモ
グリク酸ナトリウムに相当するヒアルロニダーゼ活性阻
害成分が、約20%以上含有していることになり、これ
らの抽出物は、非常に少ない添加量でヒアルロニダーゼ
活性阻害剤原料として使用することができる。(3) Discussion The extract of Eugenia polyantha Wight and the like is extracted at a concentration of 10% based on the crushed dried plant. % Or less. On the other hand, sodium cromoglycate has a 0.2% concentration and the same degree of inhibition as when 10% of a plant extract is added. From these results, each extract contains about 20% or more of a hyaluronidase activity inhibitory component corresponding to sodium cromoglycate, and these extracts can be prepared with a very small amount of the hyaluronidase activity inhibitor. Can be used as raw material.
【0048】〔実施例2:ヘアレスマウス紫外線照射法
による皮膚改善度試験〕実施例1の結果からこれらの植
物抽出液に肌弛み・肌荒れを改善することが期待された
ので実施例3処方例1及び処方例3についてヘアレスマ
ウス紫外線照射法による皮膚改善度試験を実施した。 (1)測定方法 予め一日一定量の紫外線(UVA)照射量を4ヶ月間照
射し、肌弛み・肌荒れを誘発したヘアレスマウスを作製
した。これらのヘアレスマウス(HR−1 ♀)を5群
(1群8匹)にグルーピングし、表2処方のクリーム、
乳液等を朝晩の1日2回、ヘアレスマウス背面部に連続
塗布し、3ヶ月後に肌弛み・肌荒れの改善度を表3に示
す基準にて調べた。また別途、連続塗布における発疹、
紅斑等の副作用についても調べた。Example 2: Test of degree of skin improvement by ultraviolet irradiation method of hairless mouse From the results of Example 1, it was expected that these plant extracts would improve skin looseness and rough skin. A skin improvement test was carried out for Formulation Example 3 by a hairless mouse ultraviolet irradiation method. (1) Measuring method A hairless mouse in which loosening and rough skin were induced was previously produced by irradiating a fixed amount of ultraviolet light (UVA) daily for 4 months. These hairless mice (HR-1♀) were grouped into 5 groups (8 mice per group),
Emulsion and the like were continuously applied to the back of the hairless mouse twice a day in the morning and evening, and after three months, the degree of improvement in loosening and rough skin was examined based on the criteria shown in Table 3. Also, separately, rash in continuous application,
Side effects such as erythema were also examined.
【0049】[0049]
【表2】 [Table 2]
【0050】[0050]
【表3】 [Table 3]
【0051】(2)試験結果 ヘアレスマウス紫外線照射法による肌弛み・肌荒れ改善
度試験の結果を表4に示した。表中の数字は、匹数を示
す。結果は、「改善度」を1+、「改善度2」を2+と
し、総和で示した。抽出液配合処方のNo.2試料及びN
o.4試料は、各々の基剤と比較しても著しい小肌弛み・
肌荒れ改善効果を示した。連続使用においても皮膚異常
は何ら認められなかった。(2) Test Results Table 4 shows the results of a test on the degree of improvement in skin looseness / roughness by ultraviolet irradiation of a hairless mouse. The numbers in the table indicate the number of animals. The results were expressed as a sum total, with “improvement degree” being 1+ and “improvement degree 2” being 2+. Extract No. 2 sample and N
o.4 sample has significant small skin looseness compared to each base.
The effect of improving rough skin was shown. No skin abnormalities were observed even after continuous use.
【0052】[0052]
【表4】 [Table 4]
【0053】(3)考察 Eugenia aromatica O.K.及び Uncaria gambir (Hunter)
Roxb.抽出液含有化粧料において副作用なく、著しい肌
弛み・肌荒れ改善効果が認められた。ヒアルロニダーゼ
活性阻害作用を有する他の抽出液においても同様改善効
果が期待できる。(3) Discussion Eugenia aromatica OK and Uncaria gambir (Hunter)
Roxb. Extract-containing cosmetics showed remarkable effects of improving skin looseness and roughness without side effects. The same improvement effect can be expected in other extracts having a hyaluronidase activity inhibitory effect.
【0054】[0054]
〔皮膚外用剤の調製〕下記の処方で、上記製造例で得た
抽出液を有効成分として用い、下記に示す組成にて皮膚
外用剤を調製した。処方例の配合中、「適量」とは、全
体で100重量%になる量を意味する。[Preparation of external preparation for skin] An external preparation for skin was prepared according to the following formulation and using the extract obtained in the above Preparation Example as an active ingredient, with the composition shown below. In the formulation of the formulation example, “appropriate amount” means an amount that becomes 100% by weight in total.
【0055】 <処方例1 クリーム> A (重量%) モノステアリン酸 ポリエチレングリコール(40.E.O.) 2.0 自己乳化型モノステアリン酸グリセリン 5.0 ステアリン酸 5.0 ベヘニルアルコール 1.0 流動パラフィン 10.0 トリオクタン酸グリセリル 10.0 B グリセリン 5.0 エチルパラベン 0.1 製造例3抽出液 2.0 精製水 適量 Aに属する成分を加熱溶解する。別に、Bに属する成分
を加熱溶解する。AにBを添加して撹拌、乳化後、冷却
してクリームを製造した。<Formulation Example 1 Cream> A (% by weight) Polyethylene glycol monostearate (40.EO) 2.0 Self-emulsifying glyceryl monostearate 5.0 Stearic acid 5.0 Behenyl alcohol 1.0 Fluid Paraffin 10.0 10.0 Glyceryl trioctanoate 10.0 B Glycerin 5.0 Ethylparaben 0.1 Production Example 3 Extraction 2.0 Purified Water Appropriate Amount The components belonging to A are dissolved by heating. Separately, the components belonging to B are dissolved by heating. B was added to A, stirred, emulsified and then cooled to produce a cream.
【0056】 <処方例2 クリーム> A (重量%) モノステアリン酸 ポリエチレングリコール(40.E.O.) 2.0 自己乳化型モノステアリン酸グリセリン 5.0 ステアリン酸 5.0 ベヘニルアルコール 1.0 流動パラフィン 10.0 トリオクタン酸グリセリル 10.0 製造例17抽出液 1.0 B グリセリン 5.0 エチルパラベン 0.1 精製水 適量 Aに属する成分を加熱溶解する。別に、Bに属する成分
を加熱溶解する。AにBを添加して撹拌、乳化後、冷却
してクリームを製造した。<Formulation Example 2 Cream> A (% by weight) Polyethylene glycol monostearate (40.EO) 2.0 Self-emulsifying glyceryl monostearate 5.0 Stearic acid 5.0 Behenyl alcohol 1.0 Fluid Paraffin 10.0 Glyceryl trioctanoate 10.0 Production Example 17 Extract 1.0 B Glycerin 5.0 Ethylparaben 0.1 Purified water Appropriate amount Components belonging to A are dissolved by heating. Separately, the components belonging to B are dissolved by heating. B was added to A, stirred, emulsified and then cooled to produce a cream.
【0057】 <処方例3 乳液> A (重量%) モノステアリン酸 ポリオキシエチレンソルビタン(20.E.O.) 1.0 モノステアリン酸 ポリオキシエチレンソルビタン(60.E.O.) 0.5 親油型モノステアリン酸グリセリン 1.0 ステアリン酸 0.5 ベヘニルアルコール 0.5 アボカド油 4.0 トリオクタン酸グリセリル 4.0 B 1,3−ブチレングリコール 5.0 製造例15抽出液 2.0 エチルパラベン 0.1 精製水 適量 Aに属する成分を加熱溶解する。別に、Bに属する成分
を加熱溶解する。AにBを添加して撹拌、乳化後、冷却
して乳液を製造した。<Formulation Example 3 Emulsion> A (% by weight) Polyoxyethylene sorbitan monostearate (20.EO) 1.0 Polyoxyethylene sorbitan monostearate (60.EO) 0.5 Lipophilic glyceryl monostearate 1.0 Stearic acid 0.5 Behenyl alcohol 0.5 Avocado oil 4.0 Glyceryl trioctanoate 4.0 B 1,3-butylene glycol 5.0 Preparation example 15 extract 2.0 Ethyl paraben 0.1 Suitable amount of purified water Heat and dissolve components belonging to A. Separately, the components belonging to B are dissolved by heating. B was added to A, stirred, emulsified, and cooled to produce an emulsion.
【0058】 <処方例4 化粧水> (重量%) エタノール 15.0 製造例4抽出液 1.0 エチルパラベン 0.1 クエン酸 0.1 クエン酸ナトリウム 0.3 1,3−ブチレングリコール 4.0 エデト酸二ナトリウム 0.01 精製水 適量 上記の各成分を混合、均一に撹拌、溶解し、化粧水を製
造した。<Prescription Example 4 Lotion> (Weight%) Ethanol 15.0 Production Example 4 Extract 1.0 Ethylparaben 0.1 Citric Acid 0.1 Sodium Citrate 0.3 1,3-butylene glycol 4. 0 Disodium edetate 0.01 Purified water Appropriate amount The above components were mixed, uniformly stirred and dissolved to produce a lotion.
【0059】 <処方例5 親水性軟膏> A (重量%) ポリオキシエチレンセチルエーテル 2.0 グリセリンモノステアレート 10.0 流動パラフィン 10.0 ワセリン 4.0 セタノール 5.0 製造例3抽出液 1.0 B プロピレングリコール 10.0 メチルパラベン 0.1 精製水 適量 Aに属する成分を加熱溶解する。別に、Bに属する成分
を加熱溶解する。AにBを添加して撹拌、乳化後、冷却
して親水性軟膏を製造した。Formulation Example 5 Hydrophilic ointment A (% by weight) Polyoxyethylene cetyl ether 2.0 Glycerin monostearate 10.0 Liquid paraffin 10.0 Vaseline 4.0 Cetanol 5.0 Production Example 3 Extract 1 0.0 B Propylene glycol 10.0 Methyl paraben 0.1 Purified water Appropriate amount The component belonging to A is dissolved by heating. Separately, the components belonging to B are dissolved by heating. B was added to A, stirred, emulsified, and cooled to produce a hydrophilic ointment.
【0060】〔クッキーの製造〕製造例6で得た抽出液
を有効成分として用い、下記に示す組成にてクッキーを
製造した。 <処方例6 クッキー> A (重量%) ショートニング 17.4 ショ糖 24.0 生クリーム 10.0 卵 9.0 製造例6抽出液 4.0 B 薄力小麦粉 34.0 炭酸水素ナトリウム 0.6 食塩(塩化ナトリウム) 1.0 Aに属するものをよくすり合わせ、混合する。Bに属す
るものを合わせて篩いで2回ふるう。AにBを混ぜ合わ
せる。混ぜ合わせたものを天板にスプーンで円盤状に流
す。150℃に熱した天火で約20分間焼きクッキーを
製造した。[Manufacture of Cookie] Using the extract obtained in Production Example 6 as an active ingredient, a cookie was manufactured with the following composition. <Formulation Example 6 Cookie> A (% by weight) Shortening 17.4 Sucrose 24.0 Fresh cream 10.0 Egg 9.0 Production Example 6 Extract 4.0 B Light flour 34.0 Sodium hydrogencarbonate 0.6 Salts (sodium chloride) 1.0 A belonging to A are thoroughly mixed and mixed. Combine those belonging to B and sieve twice with a sieve. Mix A with B. Sprinkle the mixture on a baking sheet in a disk shape with a spoon. A baked cookie was prepared for about 20 minutes on a fire heated to 150 ° C.
【0061】〔内服剤の調製〕製造例1で得た抽出液を
有効成分として用い、下記に示す組成にて内服剤を調製
した。 <処方例7 顆粒剤> (重量%) 製造例1抽出液 1.0 乳糖 30.0 コーンスターチ 60.0 結晶セルロース 8.0 ポリビニールピロリドン 1.0 ポリビニールピロリドンを50%エタノールに溶解し、
これを乳糖、結晶セルロース、コーンスターチに添加
し、均一に混合し、顆粒装置を用い、造粒する。乾燥後
整粒し、顆粒剤を製造した。[Preparation of Internal Preparation] An internal preparation having the following composition was prepared using the extract obtained in Production Example 1 as an active ingredient. <Formulation Example 7 Granules> (% by weight) Production Example 1 Extract 1.0 Lactose 30.0 Corn Starch 60.0 Crystalline Cellulose 8.0 Polyvinylpyrrolidone 1.0 Polyvinylpyrrolidone was dissolved in 50% ethanol,
This is added to lactose, crystalline cellulose and corn starch, mixed uniformly, and granulated using a granulator. After drying, the granules were sized to produce granules.
【0062】〔錠菓の調製〕製造例13で得た抽出液を
有効成分として用い、下記に示す組成にて錠菓を調製し
た。 <処方例8 錠菓> (重量%) クエン酸 1.0 脱脂粉乳 15.0 ショ糖エステル 1.0 フレバー 0.8 粉糖 20.0 製造例13抽出液 1.0 乳糖 62.0 上記原料を均一に混合し、50%エタノール溶液を適量
添加し、顆粒装置を用い、造粒する。乾燥後、これを打
錠し、錠菓を製造した。[Preparation of Tablets] Tablets were prepared with the following composition using the extract obtained in Production Example 13 as an active ingredient. <Formulation Example 8 Tablets> (wt%) citric acid 1.0 skim milk powder 15.0 sucrose ester 1.0 flaver 0.8 powdered sugar 20.0 Production Example 13 Extract 1.0 lactose 62.0 Is uniformly mixed, an appropriate amount of a 50% ethanol solution is added, and granulation is performed using a granulator. After drying, it was tableted to produce tablet confections.
【0063】[0063]
【発明の効果】本発明に係わる植物の抽出液は、優れた
ヒアルロニダーゼ活性阻害作用を有しているため、化粧
料、医薬品、医薬部外品および食品等老化防止を目的と
するあらゆる分野に応用してその効果を発揮することが
できる。EFFECTS OF THE INVENTION The plant extract according to the present invention has an excellent inhibitory effect on hyaluronidase activity, and can be applied to all fields for preventing aging such as cosmetics, pharmaceuticals, quasi-drugs and foods. The effect can be exerted.
フロントページの続き (51)Int.Cl.6 識別記号 FI C12N 9/99 C12N 9/99 // A21D 13/08 A21D 13/08 C09K 15/34 C09K 15/34 (72)発明者 大志万 浩一 大阪市中央区北浜4丁目7番28号 住友林 業株式会社内Continued on the front page (51) Int.Cl. 6 Identification symbol FI C12N 9/99 C12N 9/99 // A21D 13/08 A21D 13/08 C09K 15/34 C09K 15/34 (72) Inventor Koichi Oshima Osaka 4-7-28 Kitahama, Chuo-ku, Yokohama City Sumitomo Forestry Co., Ltd.
Claims (6)
ドネシア名:Babakan salam)、 学名:Cinnamomum burmani Nees ex Bl.(インドネシア
名:Kayu manis)、 学名:Eugenia aromatica O.K.(インドネシア名:Ce
ngkeh)、 学名:Quercus lusitanica Lamk (インドネシア名:M
ajakani)、 学名:Elaeocarpus ganitrus Roxb.(インドネシア名:
Jenitri)、 学名:Elaeocarpus oxypyrena K.& V.(インドネシア
名:Jenitri)、 学名:Elaeocarpus stipularis Bl.(インドネシア名:
Jenitri)、 学名:Punica granatum L.(インドネシア名:Deli
ma putih)、 学名:Terminalia belerica Roxb. (インドネシア名:
Jaha)、 学名:Cinnamomum cassia Nees ex B1. (インドネシア
名:Kembang lawang)、 学名:Eugenia cumini Merr.(インドネシア名:Bab
akan duwet)、 学名:Anacardium occidentale L. (インドネシア名:
Daun jambumete)、 学名:Guazuma ulmifolia Lmk var. tomentosa K.Schu
m. (インドネシア名:Daun jati bela
nda)、 学名:Moschosma polystachyon (L.) Bth.(インドネシ
ア名:Daun sangket)、 学名:Uncaria gambir (Hunter) Roxb. (インドネシア
名:Gambir)、 学名:Adenostemma lavenia(L.)O.K. (インドネシア
名:Legetan warak)、 学名:Pluchea indica(L.)Less(インドネシア名:Lu
ntas)、 学名:Hyptis brevipes Poit. (インドネシア名:Go
ndong puser)、 からなる群より選ばれる少なくとも一種以上の植物の溶
媒抽出液を有効成分として含有することを特徴とするヒ
アルロニダーゼ活性阻害剤。[Claim 1] Scientific name: Eugenia polyantha Wight (Indonesia name: Babakan salam), Scientific name: Cinnamomum burmani Nees ex Bl. (Indonesia name: Kayu manis), Scientific name: Eugenia aromatica OK (Indonesia name: Ce)
ngkeh), Scientific name: Quercus lusitanica Lamk (Indonesia name: M
ajakani), Scientific name: Elaeocarpus ganitrus Roxb. (Indonesia name:
Jenitri), Scientific name: Elaeocarpus oxypyrena K. & V. (Indonesia name: Jenitri), Scientific name: Elaeocarpus stipularis Bl. (Indonesia name:
Jenitri), Scientific name: Punica granatum L. (Indonesia name: Deli)
ma putih), Scientific name: Terminalia belerica Roxb. (Indonesia name:
(Jaha), Scientific name: Cinnamomum cassia Nees ex B1. (Indonesia name: Kembang lawang), Scientific name: Eugenia cumini Merr. (Indonesia name: Bab)
akan duwet), Scientific name: Anacardium occidentale L. (Indonesia name:
Daun jambume), Scientific name: Guazuma ulmifolia Lmk var. Tomentosa K. Schu
m. (Indonesia name: Daun jati bela
nda), Scientific name: Moschosma polystachyon (L.) Bth. (Indonesia name: Daun sangket), Scientific name: Uncaria gambir (Hunter) Roxb. (Indonesia name: Gambir), Scientific name: Adenostemma lavenia (L.) OK Legetan warak), Scientific name: Pluchea indica (L.) Less (Indonesia name: Lu)
ntas), Scientific name: Hyptis brevipes Poit. (Indonesia name: Go)
and a solvent extract of at least one plant selected from the group consisting of: a hyaluronidase activity inhibitor as an active ingredient.
ドネシア名:Babakan salam)の樹皮、
根、葉および実、 学名:Cinnamomum burmani Nees ex Bl.(インドネシア
名:Kayu manis)の樹皮、 学名:Eugenia aromatica O.K.(インドネシア名:Ce
ngkeh)花蕾、花および葉、 学名:Quercus lusitanica Lamk (インドネシア名:M
ajakani)の虫えい、実および葉、 学名:Elaeocarpus ganitrus Roxb.(インドネシア名:
Jenitri)の実、 学名:Elaeocarpus oxypyrena K.& V.(インドネシア
名:Jenitri)の実、 学名:Elaeocarpus stipularis Bl.(インドネシア名:
Jenitri)の実、 学名:Punica granatum L.(インドネシア名:Deli
ma putih)の果皮、根被、花および実、 学名:Terminalia belerica Roxb. (インドネシア名:
Jaha)の実、 学名:Cinnamomum cassia Nees ex B1. (インドネシア
名:Kembang lawang)の実、根および樹
皮、 学名:Eugenia cumini Merr.(インドネシア名:Bab
akan duwet)の樹皮、葉、実および種子、 学名:Anacardium occidentale L. (インドネシア名:
Daun jambumete)の葉、根、樹皮、実、
種子、 学名:Guazuma ulmifolia Lmk var. tomentosa K.Schu
m. (インドネシア名:Daun jati bela
nda)の葉、実、樹皮および種子、 学名:Moschosma polystachyon (L.) Bth.(インドネシ
ア名:Daun sangket)の全草および葉、 学名:Uncaria gambir (Hunter) Roxb. (インドネシア
名:Gambir)の茎、葉および樹液、 学名:Adenostemma lavenia(L.)O.K. (インドネシア
名:Legetan warak)の全草、根および
葉、 学名:Pluchea indica(L.)Less(インドネシア名:Lu
ntas)の茎、葉、根、種子および樹液、および、 学名:Hyptis brevipes Poit. (インドネシア名:Go
ndong puser)の葉および茎、 からなる群より選ばれる少なくとも一種以上の植物の溶
媒抽出液を有効成分として含有することを特徴とするヒ
アルロニダーゼ活性阻害剤。2. Bark of scientific name: Eugenia polyantha Wight (Indonesia name: Babakan salam),
Root, leaf and fruit, Scientific name: Bark of Cinnamomum burmani Nees ex Bl. (Indonesia name: Kayu manis) Scientific name: Eugenia aromatica OK (Indonesia name: Ce)
ngkeh) flower buds, flowers and leaves, scientific name: Quercus lusitanica Lamk (Indonesia name: M
ajakani) insects, fruits and leaves, scientific name: Elaeocarpus ganitrus Roxb. (Indonesia name:
Jenitri) Fruit, Scientific name: Elaeocarpus oxypyrena K. & V. (Indonesia name: Jenitri) Fruit, Scientific name: Elaeocarpus stipularis Bl. (Indonesia name:
Jenitri fruit, Scientific name: Punica granatum L. (Indonesia name: Deli)
ma putih) peel, root cover, flower and fruit, Scientific name: Terminalia belerica Roxb. (Indonesia name:
(Jaha) Fruit, Scientific name: Cinnamomum cassia Nees ex B1. (Indonesia name: Kembang lawang) Fruit, root and bark, Scientific name: Eugenia cumini Merr. (Indonesia name: Bab)
akan duwet bark, leaves, nuts and seeds, scientific name: Anacardium occidentale L. (Indonesia name:
Daun jambumete) leaves, roots, bark, nuts,
Seed, scientific name: Guazuma ulmifolia Lmk var. Tomentosa K. Schu
m. (Indonesia name: Daun jati bela
nda) leaves, nuts, bark and seeds, scientific name: whole plant and leaves of Moschosma polystachyon (L.) Bth. (Indonesia name: Daun sangket), scientific name: Uncaria gambir (Hunter) Roxb. (Indonesia name: Gambir) Stem, leaf and sap, Scientific name: Adenostemma lavenia (L.) OK (Indonesia name: Legetan warak) Whole plant, root and leaf, Scientific name: Pluchea indica (L.) Less (Indonesia name: Lu)
nata) stem, leaves, roots, seeds and sap, and scientific name: Hyptis brevipes Poit. (Indonesia name: Go
a hyaluronidase activity inhibitor comprising, as an active ingredient, a solvent extract of at least one plant selected from the group consisting of:
ゼ活性阻害剤を含有する化粧料。3. A cosmetic comprising the hyaluronidase activity inhibitor according to claim 1 or 2.
ゼ活性阻害剤を含有する医薬品。4. A pharmaceutical comprising the hyaluronidase activity inhibitor according to claim 1 or 2.
ゼ活性阻害剤を含有する医薬部外品。5. A quasi-drug containing the hyaluronidase activity inhibitor according to claim 1 or 2.
ゼ活性阻害剤を含有する食品。6. A food containing the hyaluronidase activity inhibitor according to claim 1 or 2.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10209861A JPH11106311A (en) | 1997-07-31 | 1998-07-24 | Hyaluronidase activity inhibitor and its use |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP20576297 | 1997-07-31 | ||
| JP9-205762 | 1997-07-31 | ||
| JP10209861A JPH11106311A (en) | 1997-07-31 | 1998-07-24 | Hyaluronidase activity inhibitor and its use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH11106311A true JPH11106311A (en) | 1999-04-20 |
Family
ID=26515239
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP10209861A Pending JPH11106311A (en) | 1997-07-31 | 1998-07-24 | Hyaluronidase activity inhibitor and its use |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH11106311A (en) |
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20010018668A (en) * | 1999-08-20 | 2001-03-15 | 유상옥 | A cosmetic composition containing Cinnamomi Cortex extracts |
| KR20010055960A (en) * | 1999-12-13 | 2001-07-04 | 유상옥,송운한 | Skin care composition containing Cinnamomum cassia extract |
| JP2004256485A (en) * | 2003-02-27 | 2004-09-16 | Takayuki Izumi | Skin care preparation for external use |
| JP2005053873A (en) * | 2003-08-07 | 2005-03-03 | Sakamoto Yakusoen:Kk | Elastase inhibitor and composition containing the same |
| JP2008143784A (en) * | 2006-12-06 | 2008-06-26 | B & C Laboratories Inc | Cell growth promoter |
| JP2009249365A (en) * | 2008-04-10 | 2009-10-29 | Kose Corp | Cell activator and anti-aging skin preparation for external use |
| JP2009249366A (en) * | 2008-04-10 | 2009-10-29 | Kose Corp | Collagen production promotor and anti-aging skin preparation for external use |
| JP2010047497A (en) * | 2008-08-20 | 2010-03-04 | B & C Laboratories Inc | Elastin production promoting agent |
| WO2012077976A3 (en) * | 2010-12-07 | 2012-09-07 | 한국생명공학연구원 | Anti-aging composition containing elaeocarpus petiolatus extract or fraction thereof as active ingredient |
| KR101425560B1 (en) * | 2010-12-07 | 2014-08-04 | 한국생명공학연구원 | Composition for antioxidant comprising extracts or its fractions of Elaeocarpus petiolatus as an active ingredient |
| WO2017145958A1 (en) * | 2016-02-24 | 2017-08-31 | Kao Corporation | Whitening agent comprising as active agent syzygium polyanthum or an extract thereof |
Citations (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0211520A (en) * | 1988-06-29 | 1990-01-16 | Momotani Jiyuntenkan:Kk | Hyaluronidase inactivation agent |
| JPH03209330A (en) * | 1990-01-09 | 1991-09-12 | Kanebo Ltd | Anti-inflammatory composition |
| JPH069371A (en) * | 1992-06-23 | 1994-01-18 | Mikimoto Pharmaceut Co Ltd | Hyaluronidase inhibitor |
| JPH0616530A (en) * | 1992-07-03 | 1994-01-25 | Mikimoto Pharmaceut Co Ltd | Cosmetic |
| JPH0680553A (en) * | 1992-09-03 | 1994-03-22 | Mikimoto Pharmaceut Co Ltd | Hyaluronidase inhibitor |
| JPH06239757A (en) * | 1993-02-17 | 1994-08-30 | Chugai Pharmaceut Co Ltd | Antiallergic agent |
| JPH0853360A (en) * | 1994-06-10 | 1996-02-27 | Suntory Ltd | Histamine liberation inhibitor and cosmetic and food product containing the same |
| JPH0867618A (en) * | 1994-08-31 | 1996-03-12 | Tsuneo Nanba | Cosmetic |
| JPH08333267A (en) * | 1995-06-02 | 1996-12-17 | Maruzen Pharmaceut Co Ltd | Antiallergic agent |
| JPH0967251A (en) * | 1995-08-31 | 1997-03-11 | Nagase & Co Ltd | Hyaluronidase inhibitor containing rosmarinic acid as active ingredient |
| JPH0987189A (en) * | 1995-09-19 | 1997-03-31 | Ichimaru Pharcos Co Ltd | Antiallergic agent containing isodon japonicus hara, paeonia suffruticosa andrews, perilla frutescens britton var. acuta kudo, and/or arunica montana linne |
| JPH0987197A (en) * | 1995-07-13 | 1997-03-31 | Shiseido Co Ltd | Tyrosinase inhibitor |
| JPH09110710A (en) * | 1995-10-24 | 1997-04-28 | Ichimaru Pharcos Co Ltd | Dermal preparation for external use and bathing agent |
| JPH1036276A (en) * | 1996-07-17 | 1998-02-10 | Noevir Co Ltd | Antiallergic agent and antiallergic cosmetic material and food containing the same |
| JPH10130162A (en) * | 1996-10-31 | 1998-05-19 | Kanebo Ltd | Hyaluronic acid decomposition inhibitor, agent for treatment of hyaluronic acid abnormal decomposition disease and cosmetic |
| JPH115975A (en) * | 1997-04-23 | 1999-01-12 | Sansho Seiyaku Co Ltd | Active oxygen scavenger and use thereof |
| JPH11116492A (en) * | 1997-07-31 | 1999-04-27 | Sansho Seiyaku Co Ltd | Melanin formation inhibitor and its use |
-
1998
- 1998-07-24 JP JP10209861A patent/JPH11106311A/en active Pending
Patent Citations (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0211520A (en) * | 1988-06-29 | 1990-01-16 | Momotani Jiyuntenkan:Kk | Hyaluronidase inactivation agent |
| JPH03209330A (en) * | 1990-01-09 | 1991-09-12 | Kanebo Ltd | Anti-inflammatory composition |
| JPH069371A (en) * | 1992-06-23 | 1994-01-18 | Mikimoto Pharmaceut Co Ltd | Hyaluronidase inhibitor |
| JPH0616530A (en) * | 1992-07-03 | 1994-01-25 | Mikimoto Pharmaceut Co Ltd | Cosmetic |
| JPH0680553A (en) * | 1992-09-03 | 1994-03-22 | Mikimoto Pharmaceut Co Ltd | Hyaluronidase inhibitor |
| JPH06239757A (en) * | 1993-02-17 | 1994-08-30 | Chugai Pharmaceut Co Ltd | Antiallergic agent |
| JPH0853360A (en) * | 1994-06-10 | 1996-02-27 | Suntory Ltd | Histamine liberation inhibitor and cosmetic and food product containing the same |
| JPH0867618A (en) * | 1994-08-31 | 1996-03-12 | Tsuneo Nanba | Cosmetic |
| JPH08333267A (en) * | 1995-06-02 | 1996-12-17 | Maruzen Pharmaceut Co Ltd | Antiallergic agent |
| JPH0987197A (en) * | 1995-07-13 | 1997-03-31 | Shiseido Co Ltd | Tyrosinase inhibitor |
| JPH0967251A (en) * | 1995-08-31 | 1997-03-11 | Nagase & Co Ltd | Hyaluronidase inhibitor containing rosmarinic acid as active ingredient |
| JPH0987189A (en) * | 1995-09-19 | 1997-03-31 | Ichimaru Pharcos Co Ltd | Antiallergic agent containing isodon japonicus hara, paeonia suffruticosa andrews, perilla frutescens britton var. acuta kudo, and/or arunica montana linne |
| JPH09110710A (en) * | 1995-10-24 | 1997-04-28 | Ichimaru Pharcos Co Ltd | Dermal preparation for external use and bathing agent |
| JPH1036276A (en) * | 1996-07-17 | 1998-02-10 | Noevir Co Ltd | Antiallergic agent and antiallergic cosmetic material and food containing the same |
| JPH10130162A (en) * | 1996-10-31 | 1998-05-19 | Kanebo Ltd | Hyaluronic acid decomposition inhibitor, agent for treatment of hyaluronic acid abnormal decomposition disease and cosmetic |
| JPH115975A (en) * | 1997-04-23 | 1999-01-12 | Sansho Seiyaku Co Ltd | Active oxygen scavenger and use thereof |
| JPH11116492A (en) * | 1997-07-31 | 1999-04-27 | Sansho Seiyaku Co Ltd | Melanin formation inhibitor and its use |
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20010018668A (en) * | 1999-08-20 | 2001-03-15 | 유상옥 | A cosmetic composition containing Cinnamomi Cortex extracts |
| KR20010055960A (en) * | 1999-12-13 | 2001-07-04 | 유상옥,송운한 | Skin care composition containing Cinnamomum cassia extract |
| JP2004256485A (en) * | 2003-02-27 | 2004-09-16 | Takayuki Izumi | Skin care preparation for external use |
| JP2005053873A (en) * | 2003-08-07 | 2005-03-03 | Sakamoto Yakusoen:Kk | Elastase inhibitor and composition containing the same |
| JP2008143784A (en) * | 2006-12-06 | 2008-06-26 | B & C Laboratories Inc | Cell growth promoter |
| JP2009249365A (en) * | 2008-04-10 | 2009-10-29 | Kose Corp | Cell activator and anti-aging skin preparation for external use |
| JP2009249366A (en) * | 2008-04-10 | 2009-10-29 | Kose Corp | Collagen production promotor and anti-aging skin preparation for external use |
| JP2010047497A (en) * | 2008-08-20 | 2010-03-04 | B & C Laboratories Inc | Elastin production promoting agent |
| WO2012077976A3 (en) * | 2010-12-07 | 2012-09-07 | 한국생명공학연구원 | Anti-aging composition containing elaeocarpus petiolatus extract or fraction thereof as active ingredient |
| KR101425560B1 (en) * | 2010-12-07 | 2014-08-04 | 한국생명공학연구원 | Composition for antioxidant comprising extracts or its fractions of Elaeocarpus petiolatus as an active ingredient |
| WO2017145958A1 (en) * | 2016-02-24 | 2017-08-31 | Kao Corporation | Whitening agent comprising as active agent syzygium polyanthum or an extract thereof |
| US11090351B2 (en) | 2016-02-24 | 2021-08-17 | Kao Corporation | Whitening agent |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5683134B2 (en) | Topical skin preparation | |
| KR20110131498A (en) | An antimicrobial agent comprising silver ions in an alkaline solution extracted from shells or shellfish lakes and a composition comprising the same. | |
| CN110731991A (en) | Composition for external use on skin with anti-acne effect | |
| Srirod et al. | Anti-inflammatory and wound healing effects of cream containing Curcuma mangga extract | |
| KR20140115400A (en) | Composition of scalp care for prevention of depilation and improvement of hair growth comprising Rhus javanica L. Extracts | |
| WO2021017910A1 (en) | External skin treatment composition with enhanced anti-inflammatory effect | |
| JP2011246353A5 (en) | ||
| KR20180138399A (en) | Inhibitor for NO activator, Anit-inflammation agent containing of the same, Revitalizing cosmetics containing the same and Manufacturing method thereof | |
| KR20150007975A (en) | Composition for promoting hair growth and restoration | |
| JP4831849B2 (en) | Active oxygen scavenger and its use | |
| JPH11116492A (en) | Melanin formation inhibitor and its use | |
| JPH11106311A (en) | Hyaluronidase activity inhibitor and its use | |
| JPH0725763A (en) | Deramatic agent for external use | |
| TWI392518B (en) | Cosmetics containing diethylene glycol diol diol | |
| KR20200005188A (en) | composition for preventing or treating of wound comprising Indirubin derivative compound | |
| Mamillapalli et al. | Formulation, phytochemical, physical, biological evaluation of polyherbal vanishing cream, and facewash | |
| KR20140145278A (en) | Cosmetic composition containing Cimicifuga heracleifolia extract, Cornus officinalis extract and Geranium nepalense extract for skin convergence and elasticity effect | |
| KR101419588B1 (en) | Composition for Moisturizing Skin Comprising Ginseng Oil as Active Ingredient | |
| KR101347910B1 (en) | a Food Composition, a Cosmetic Composition, a Pharmaceutical Composition Comprising Supercritical Fluid Extract of Ginger and Extract of Dropwort Fermented | |
| JP3273812B2 (en) | Cosmetics | |
| JP4155430B2 (en) | Skin aging inhibitor and use thereof | |
| JP2005281205A (en) | Macrophage activator | |
| JP3496967B2 (en) | Antiplasmin agent | |
| KR100345226B1 (en) | Whitening cosmetic composition including the extract of the fruits of Melia azedarach or M. toosendan | |
| JP2010018545A (en) | Active oxygen scavenger, and skin care preparation for external use, composition for oral cavity and food |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20040210 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040412 |
|
| A911 | Transfer of reconsideration by examiner before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20040622 |
|
| A912 | Removal of reconsideration by examiner before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A912 Effective date: 20050204 |